Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;36(2):e3207.
doi: 10.1002/dmrr.3207. Epub 2019 Aug 13.

The remission phase in type 1 diabetes: Changing epidemiology, definitions, and emerging immuno-metabolic mechanisms

Ting Zhong  1   2 , Rong Tang  1   2 , Siyuan Gong  1   2 , Juan Li  1   2 , Xia Li  1   2 , Zhiguang Zhou  1   2
Affiliations
Review

The remission phase in type 1 diabetes: Changing epidemiology, definitions, and emerging immuno-metabolic mechanisms

Ting Zhong et al. Diabetes Metab Res Rev. 2020 Feb.

Abstract

Type 1 diabetes mellitus (T1DM) is characterized by irreversible islet β cell destruction. During the progression of this disease, some patients with T1DM experience a phase of remission known as honeymoon or partial remission (PR) that is mainly characterized by satisfactory glycemic control and the transient recovery of islet β cell function. This special phase is a good model for studying the mechanism of β cell protection, might serve as a proper intervention period for immunotherapy, and may be related to disease prognosis. This special stage is highly valuable for studies aiming to identify possible targets that may be used to cure T1DM. An in-depth understanding of the diagnosis, epidemiology, and possible mechanisms of the PR phase is highly needed. In general, patients enter the PR phase approximately 3 months after starting insulin therapy, and this phase could be sustained for 6 to 9 months. Current research increasingly focuses on the metabolic and immunological aspects to constantly update our understanding of this phase. This review concentrates on the PR phase of T1DM to provide a comprehensive outlook of its epidemiology, diagnostic criteria, and underlying immune metabolic mechanisms.

Keywords: immuno-metabolic mechanism; remission phase; the honeymoon period; type 1 diabetes.

PubMed Disclaimer

References

REFERENCES

    1. Li X, Cheng J, Zhou Z. Revisiting multiple models of progression of β-cell loss of function in type 1 diabetes: significance for prevention and cure. J Diabetes. 2016;8(4):460-469.
    1. Chen YC, Tung YC, Liu SY, Lee CT, Tsai WY. Clinical characteristics of type 1 diabetes mellitus in Taiwanese children aged younger than 6 years: a single-center experience. J Formos Med Assoc. 2016;116:340-344.
    1. Neylon OM, Cameron FJ, Connell MA, White M. Insulin-dose-adjusted HbA1c -defined partial remission phase in a paediatric population-when is the honeymoon over? Diabetic Medicine A Journal of the British Diabetic Association. 2013;30(5):627-628.
    1. Ortqvist E, Falorni A, Scheynius A, Persson B, Lernmark Å. Age governs gender-dependent islet cell autoreactivity and predicts the clinical course in childhood IDDM. Acta Pã¦diatrica. 1997;86(11):1166-1171.
    1. Niedzwiecki P, Pilacinski S, Uruska A, Adamska A, Naskret D, Zozulinska-Ziolkiewicz D. Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes. Journal of Diabetes & Its Complications. 2015;29(8):1105-1111.

Publication types

MeSH terms

LinkOut - more resources